Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
European League Against Rheumatism (EULAR) 2020 Congress
June 03 - 06, 2020; Frankfurt, Germany
June 03 - 06, 2020Frankfurt, Germany
EULAR 2020Upadacitinib Looks Effective for Psoriatic ArthritisFindings from a pair of phase 3 trials support use of the JAK inhibitor for psoriatic arthritis; it has already been approved for rheumatoid arthritis.
Medscape Medical News, June 9, 2020
EULAR 2020Avacopan Notches a Win in ANCA-Associated VasculitisAvacopan was found to be efficacious and safe for treating antineutrophil cytoplasmic antibody–associated vasculitis in the phase 3 ADVOCATE trial.
Medscape Medical News, June 8, 2020
EULAR 2020Most Rheumatology Drugs Don't Up COVID-19 HospitalizationDespite concerns, most medications for rheumatic and musculoskeletal diseases do not appear to increase the risk for severe outcomes for COVID-19, new research suggests.
Medscape Medical News, June 4, 2020
The European League Against Rheumatism canceled the 2020 Congress
Interleukin-17 Edges TNF Inhibitor in Psoriatic ArthritisEarly outcomes for the combined end point of skin clearance and disease activity in a comparison of biologics can give physicians
confidence in the IL-17 inhibitor, SPIRIT-H2H investigators say.
Medscape Medical News, Jun 20, 2019
Nerve Stimulator Showing Promise in Rheumatoid ArthritisOnce-daily stimulation of the vagus nerve with an app-controlled implanted microregulator helped patients with refractory
rheumatoid arthritis in a small pilot study, researchers report.
Medscape Medical News, Jun 18, 2019
Imaging Can Mislead in Inflammatory ArthritisTests can help clinicians assess patients with suspected inflammatory arthritis, but 'it shouldn't drive' treatment, an expert
reminds rheumatologists.
